Leishmania tropica is one of the causative agents of leishmaniasis in humans. Routes of infection have been reported to be an important variable for some species of Leishmania parasites. The role of this variable is not clear for L. tropica infection. The aim of this study was to explore the effects of route of L. tropica infection on the disease outcome and immunologic parameters in BALB/c mice. Two routes were used; subcutaneous in the footpad and intradermal in the ear. Mice were challenged by Leishmani major, after establishment of the L. tropica infection, to evaluate the level of protective immunity. Immune responses were assayed at week 1 and week 4 after challenge. The subcutaneous route in the footpad in comparison to the intradermal route in the ear induced significantly more protective immunity against L. major challenge, including higher delayed-type hypersensitivity responses, more rapid lesion resolution, lower parasite loads, and lower levels of IL-10. Our data showed that the route of infection in BALB/c model of L. tropica infection is an important variable and should be considered in developing an appropriate experimental model for L. tropica infections.
Citations
Citations to this article as recorded by
The Immune Memory Response of In Vitro-Polarised Th1, Th2, and Th17 Cells in the Face of Ovalbumin-Transgenic Leishmania major in a Mouse Model Mebrahtu G. Tedla, Musammat F. Nahar, Alison L. Every, Jean-Pierre Y. Scheerlinck International Journal of Molecular Sciences.2024; 25(16): 8753. CrossRef
Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Leishmania mexicana Infection Bernard Ong’ondo Osero, Zama Cele, Raphael Taiwo Aruleba, Rebeng A. Maine, Mumin Ozturk, Manfred B. Lutz, Frank Brombacher, Ramona Hurdayal Frontiers in Immunology.2022;[Epub] CrossRef
A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics Natalia Muñoz-Durango, Alexander Gómez, Natalia García-Valencia, Miguel Roldán, Marcela Ochoa, David E. Bautista-Erazo, José R. Ramírez-Pineda Frontiers in Microbiology.2022;[Epub] CrossRef
To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host Omar A. Alfituri, Juan F. Quintana, Annette MacLeod, Paul Garside, Robert A. Benson, James M. Brewer, Neil A. Mabbott, Liam J. Morrison, Paul Capewell Frontiers in Immunology.2020;[Epub] CrossRef
DermotropicLeishmania donovaniin Sri Lanka: visceralizing potential in clinical and preclinical studies K. K. G. D. U. L. KARIYAWASAM, A. SELVAPANDIYAN, H. V. Y. D. SIRIWARDANA, A. DUBE, P. KARUNANAYAKE, S. A. S. C. SENANAYAKE, R. DEY, S. GANNAVARAM, H. L. NAKHASI, N. D. KARUNAWEERA Parasitology.2018; 145(4): 443. CrossRef
Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice Mosayeb Rostamian, Fariborz Bahrami, Hamid M. Niknam, Humberto Lanz-Mendoza PLOS ONE.2018; 13(9): e0204491. CrossRef
Route of Infection Affects Pathogenicity of Leishmania major in BALB/c Mice Ehsan Sarreshteh, Mosayeb Rostamian, Mahsa Tat Asadi, Firoozeh Abrishami, Ali Najafi, Maryam Abolghazi, Hamid Mahmoudzadeh Niknam Journal of Medical Microbiology and Infectious Diseases .2017; 5(1): 26. CrossRef
Indigenous microbiota and Leishmaniasis M. E. M. Lopes, M. B. H. Carneiro, L. M. dos Santos, L. Q. Vieira Parasite Immunology.2016; 38(1): 37. CrossRef
Cross‐protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis V. T. Martins, D. P. Lage, M. C. Duarte, L. E. Costa, M. A. Chávez‐Fumagalli, B. M. Roatt, D. Menezes‐Souza, C. A. P. Tavares, E. A. F. Coelho Parasite Immunology.2016; 38(2): 108. CrossRef
Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice Lu Huang, Meleana Hinchman, Susana Mendez, Mary Ann McDowell PLOS Neglected Tropical Diseases.2015; 9(3): e0003546. CrossRef
Site-Dependent Recruitment of Inflammatory Cells Determines the Effective Dose of Leishmania major Flavia L. Ribeiro-Gomes, Eric Henrique Roma, Matheus B. H. Carneiro, Nicole A. Doria, David L. Sacks, Nathan C. Peters, J. A. Appleton Infection and Immunity.2014; 82(7): 2713. CrossRef
First
Prev
